ClinicalTrials.Veeva

Menu
A

Atlanta Center for Medical Research | Atlanta, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lurasidone
Cariprazine
Rapastinel
SEP-363856
PF-06649751
SPD489
MK-8189
KarXT
Dasotraline
Bryostatin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 212 total trials

A Study of MK-8189 in Participants With Bipolar I Disorder (MK-8189-020)

The goal of this study is to evaluate the safety and tolerability of MK-8189 in participants with stable bipolar I disorder. There will be no hypothe...

Active, not recruiting
Bipolar I Disorder
Drug: Placebo
Drug: MK-8189

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine

The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.

Enrolling
Bipolar Disorder
Drug: Placebo
Drug: BHV-7000

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.

Invitation-only
Bipolar Disorder
Drug: BHV-7000

The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.

Enrolling
Schizophrenia
Drug: Cariprazine
Drug: Placebo

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Enrolling
Treatment Resistant Depression
Drug: Psilocybin

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Active, not recruiting
Painful Lumbosacral Radiculopathy
Drug: VX-548
Drug: Placebo

The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants wit...

Enrolling
Parkinson Disease
Drug: Lu AF28996

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Enrolling
Bipolar I Disorder
Schizophrenia
Drug: Cariprazine Flexible Dose

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling
OSA
Drug: Placebo
Drug: AD109

This is a study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of FTX-6058 in participants with sickle cell disease.

Enrolling
Sickle Cell Anemia
Sickle Cell Disease
Drug: FTX-6058 oral capsule(s)

Autism spectrum disorder (ASD) consists of deficits in social, communication, and cognitive development, repetitive and stereotypic behaviors. Many A...

Active, not recruiting
Autism Spectrum Disorder
Drug: Placebo
Drug: Cariprazine

Trial sponsors

Pfizer logo
Sumitomo Pharma logo
Shire logo
AbbVie logo
Janssen (J&J Innovative Medicine) logo
Merck Sharp & Dohme (MSD) logo
Otsuka logo
Allergan logo
H
Karuna Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems